V7

V7 Labs envisions a future where machines possess vision as keen and reliable as human sight, transforming industries from healthcare to finance with AI-driven insight. By fusing artificial intelligence with deep human knowledge, V7 is crafting a world where automation is not just efficient but deeply trustworthy and transparent.

At the core of V7 Labs’ innovation is a commitment to redefining how technology perceives and interacts with the world, enabling breakthroughs in complex visual and business processes. With cutting-edge computer vision and AI automation, V7 is empowering industries to solve critical problems and unlock new realms of possibility.

The future V7 Labs is building is one where intelligent machines act as extensions of human capability, revolutionizing workflows and decision-making across countless fields through relentless innovation and integrity in AI.

V7 Labs caught our attention with its ambitious vision to give machines "sight" — and we're impressed by how they're executing on it. After diving deep into their platform and examining their track record since 2018, we can see why they've attracted major clients like GE Healthcare and Siemens.

A Fresh Take on AI Training

What stands out about V7 is their human-centric approach to machine learning. Their Darwin platform doesn't just speed up data labeling (though it does that impressively, up to 10x faster than traditional methods). It's designed to preserve human expertise while scaling it through AI. This is particularly crucial in specialized fields like medical imaging, where expert knowledge can't be compromised.

From Computer Vision to Business Intelligence

We're particularly intrigued by their evolution. While V7 started in computer vision, their expansion into business process automation with V7 Go shows they're thinking bigger. It's a clever pivot that leverages their expertise in visual AI to tackle broader workplace challenges in finance, legal, and insurance sectors.

Growth That Turns Heads

The numbers tell a compelling story: a 3x increase in annual recurring revenue and a staggering 100x boost in organic traffic (2022). That kind of growth doesn't happen by accident. Their $33 million Series A round, backed by Radical Ventures and Temasek, suggests we're not the only ones seeing their potential.

Who Should Take Notice

V7 is particularly appealing for enterprises in healthcare, biotech, and regulated industries where accuracy and auditability are non-negotiable. If you're handling complex visual data or looking to automate document-heavy processes, their platform offers a sophisticated yet accessible solution. While they're not the cheapest option out there, their focus on trustworthy AI and human expertise makes them worth considering for mission-critical applications.